Preeclampsia and antiphospholipid syndrome. Uterine artery Doppler evaluation;Prééclampsie et syndrome des antiphospholipides. Intérêt du Doppler utéroplacentaire

Revue de Medecine Interne

Volumn 27, Issue 2, 2006, Pages 111-116

  Carbillon, L ^a   Uzan, M ^a   Kettaneh, A ^a   Letellier, E ^a   Stirnemann, J ^a   Perrot, N ^a   Tigaizin, A ^a   Fain, O ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Antiphospholipid syndrome; Preeclampsia; Uterine artery Doppler velocimetry

Indexed keywords

LUPUS ANTICOAGULANT;

ANTIPHOSPHOLIPID SYNDROME; ARTERY BLOOD FLOW; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOGRAPHY; GESTATION PERIOD; HUMAN; INTRAUTERINE GROWTH RETARDATION; PLACENTA CIRCULATION; PLACENTA INSUFFICIENCY; PREDICTION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOSIS; TROPHOBLAST; UTERINE ARTERY; VASCULAR RESISTANCE;

EID: 31944436583     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.10.014     Document Type: Short Survey

References (36)

1. J.M. Roberts, and D.W. Cooper Pathogenesis and genetics of preeclampsia Lancet 357 2001 53 56
2. W.A. Wilson Classification criteria for antiphospholipid syndrome Rheum. Dis. Clin. North Am. 27 2001 499 505
3. K. Duckitt, and D. Harrington Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies BMJ 330 2005 565
4. M. Backos, R. Rai, N. Baxter, I.T. Chilcott, H. Cohen, and L. Regan Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin Br. J. Obstet. Gynaecol. 106 1999 102 107
5. L. Carbillon, M.L. Sauvet, O. Fain, and M.H. Aurousseau Treated pregnant patients with antiphospholipid syndrome are particularly susceptible to preeclampsia and fetal growth retardation J. Reprod. Immunol. 65 2005 89 90
6. L. Carbillon, M. Uzan, and S. Uzan Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation Obstet. Gynecol. Surv. 55 2000 574 581
7. L. Carbillon, J.C. Challier, S. Alouini, M. Uzan, and S. Uzan Uteroplacental circulation development: Doppler assessment and clinical importance Placenta 22 10 2001 795 799
8. I. Brosens, H.G. Dixon, and W.B. Robertson Fetal growth retardation and the arteries of the placental bed Br. J. Obstet. Gynaecol. 84 1977 656 663
9. W.B. Robertson, I. Brosens, and H.G. Dixon The pathological response of the vessels of the placental bed to hypertensive pregnancy J. Pathol. Bacteriol. 93 1967 581 592
10. P. Merviel, L. Carbillon, J.C. Challier, M. Rabreau, M. Beaufils, and S. Uzan Pathophysiology of preeclampsia: links with implantation disorders Eur. J. Obstet. Gynecol. Reprod. Biol. 115 2004 134 147
11. J.H. Rand, X.X. Wu, H.A. Andree, C.J. Lockwood, S. Guller, and J. Scher Pregnancy loss in the antiphospholipid-antibody syndrome a possible thrombogenic mechanism N. Engl. J. Med. 337 1997 154 160
12. H.A. Mousa, and Z. Alfirevicl Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum. Reprod. 15 2000 1830 1833
13. T.W. Lyden, E. Vogt, A.K. Ng, P.M. Johnson, and N.S. Rote Monoclonal antiphospholipid antibody reactivity against human placental trophoblast J. Reprod. Immunol. 22 1992 1 14
14. L.W. Chamley, A.M. Duncalf, M.D. Mitchell, and P.M. Johnson Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death Lancet 352 1998 1037 1038
15. J.H. Rand, X.X. Wu, S. Guller, J. Scher, H.A. Andree, and C.J. Lockwood Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi Am. J. Obstet. Gynecol. 177 1997 918 923
16. N.J. Sebire, H. Fox, M. Backos, R. Rai, C. Paterson, and L. Regan Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure Hum. Reprod. 17 2002 1067 1071
17. W.H. Kutteh Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone Am. J. Obstet. Gynecol. 174 1996 1584 1589
18. R. Rai, H. Cohen, M. Dave, and L. Regan Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ 314 1997 253 257
19. R.G. Farquharson, S. Quenby, and M. Greaves Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment Obstet. Gynecol. 100 2002 408 413
20. V. Sephton, R.G. Farquharson, J. Topping, S.M. Quenby, C. Cowan, and D.J. Back A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy Obstet. Gynecol. 101 2003 1307 1311
21. S.A. Steel, J.M. Pearce, P. McParland, and G.V. Chamberlain Early Doppler ultrasound screening in prediction of hypertensive disorders of pregnancy Lancet 335 8705 1990 1548 1551
22. S. Alouini, L. Carbillon, N. Perrot, S. Uzan, and M. Uzan Intervillous and spiral artery flows in normal pregnancies between 5 and 10:weeks of amenorrhea using color Doppler ultrasonography Fetal Diagn. Ther. 17 2002 163 166
23. L. Carbillon, M. Uzan, C. Largilliere, N. Perrot, A. Tigaizin, and J. Paries Prospective evaluation of uterine artery flow velocity waveforms at 12-14 and 22-24:weeks of gestation in relation to pregnancy outcome and birth weight Fetal Diagn. Ther. 19 2004 381 384
24. P.F. Chien, N. Arnott, A. Gordon, P. Owen, and K.S. Khan How useful is uterine artery Doppler flow velocimetry in the prediction of preeclampsia, intrauterine growth retardation and perinatal death? An overview BJOG 107 2000 196 208
25. A.T. Papageorghiou, C.K. Yu, S. Cicero, S. Bower, and K.H. Nicolaides Second-trimester uterine artery Doppler screening in unselected populations: a review J. Matern. Fetal Neonatal Med. 12 2002 78 88
26. J.R. Leiberman, I. Meizner, D. Fraser, Z. Meril, D. Yohay, and M. Glezerman The association between increased mean arterial pressure and abnormal uterine artery resistance to blood flow during pregnancy Obstet. Gynecol. 82 1993 965 969
27. J. Ducey, H. Schulman, G. Farmakides, B. Rochelson, L. Bracero, and A. Fleischer A classification of hypertension in pregnancy based on Doppler velocimetry Am. J. Obstet. Gynecol. 157 3 1987 680 685
28. L.M. McCowan, R.A. North, and J.E. Harding Abnormal uterine artery Doppler in small-for-gestational-age pregnancies is associated with later hypertension Aust. N. Z. J. Obstet. Gynaecol. 41 2001 56 60
29. Z. Blumenfeld, Z. Weiner, M. Lorber, P. Sujov, and I. Thaler Anticardiolipin antibodies in patients with recurrent pregnancy wastage: treatment and uterine blood flow Obstet. Gynecol. 78 1991 584 589
30. A. Caruso, S. De Carolis, S. Ferrazzani, G. Valesini, L. Caforio, and S. Mancuso Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome Obstet. Gynecol. 82 1993 970 977
31. T. Farrell, and T. Dawson Can uterine artery Doppler velocimetry predict adverse pregnancy outcome in women with antiphospholipid syndrome? Acta Obstet. Gynecol. Scand. 80 2001 609 610
32. N. Venkat-Raman, M. Backos, T.G. Teoh, W.T. Lo, L. Regan, and N. Venkat-Raman Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome Obstet. Gynecol. 98 2001 235 242
33. J. Bar, R. Mashiah, B. Cohen-Sacher, M. Hod, R. Orvieto, and Z. Ben-Rafael Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications Thromb. Res. 101 2001 235 241
34. R.P. Dickey, and J.F. Hower Effect of ovulation induction on uterine blood flow and estradiol and progesterone concentrations in early pregnancy Hum. Reprod. 10 1995 2875 2879
35. L. Carbillon, N. Perrot, M. Uzan, and S. Uzan Doppler ultrasonography and implantation: a critical review Fetal Diagn. Ther. 16 2001 327 332
36. M. Nakatsuka, T. Habara, S. Noguchi, H. Konishi, and T. Kudo Impaired uterine arterial blood flow in pregnant women with recurrent pregnancy loss J. Ultrasound Med. 22 2003 27 31